We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AMED market cap is 2.79B. The company's latest EPS is USD -0.2976 and P/E is -286.12.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 556.24M | 570.79M | 571.41M | 591.19M | 587.67M |
| Operating Income | 43.46M | 10.25M | 32.53M | 53.73M | 32.22M |
| Net Income | 25.96M | 19.32M | 14.4M | 32.3M | 16.91M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.96B | 2.07B | 2.21B | 2.22B | 2.24B |
| Operating Income | 184.28M | 188.86M | 243.56M | 183.74M | 167.15M |
| Net Income | 126.83M | 183.61M | 209.07M | 118.61M | -9.75M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.03B | 2.06B | 2.09B | 2.12B | 2.14B |
| Total Liabilities | 933.9M | 940.39M | 947.22M | 938.48M | 938.68M |
| Total Equity | 1.09B | 1.12B | 1.14B | 1.18B | 1.2B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.26B | 1.57B | 1.86B | 1.98B | 2.06B |
| Total Liabilities | 621.23M | 756.46M | 880.65M | 869.67M | 940.39M |
| Total Equity | 641.51M | 810.74M | 976.32M | 1.11B | 1.12B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 76.88M | 137.19M | -6.54M | 45.76M | 151.39M |
| Investing | 37.1M | 35.06M | -3.07M | -4.64M | -7.08M |
| Financing | -74.1M | -87.52M | -8.55M | -22.63M | -37.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 202M | 288.95M | 188.89M | 133.28M | 137.19M |
| Investing | -352.95M | -287.11M | -281.61M | -94.49M | 35.06M |
| Financing | 227.21M | -14.98M | 55.13M | -30.43M | -87.52M |
| Market Cap | 2.79B |
| Price to Earnings Ratio | -286.12 |
| Price to Sales Ratio | 1.25 |
| Price to Cash Ratio | 22.05 |
| Price to Book Ratio | 2.49 |
| Dividend Yield | - |
| Shares Outstanding | 32.75M |
| Average Volume (1 week) | 925.14k |
| Average Volume (1 Month) | 680.06k |
| 52 Week Change | -10.70% |
| 52 Week High | 98.95 |
| 52 Week Low | 82.15 |
| Spread (Intraday) | 16.68 (18.39%) |
| Company Name | Amedisys Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.amedisys.com |
| Industry | home health care services (8082) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
